Mark Muthiah
Overview
Explore the profile of Mark Muthiah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Lim W, Tay P, Ng C, Tan D, Ong C, Koh J, et al.
Aliment Pharmacol Ther
. 2024 Feb;
59(6):730-741.
PMID: 38303565
Background: Although alcohol abstinence may be an effective intervention for alcohol-associated cirrhosis, its association with prognosis has not been systematically assessed or quantified. Aims: To determine the prevalence of alcohol...
22.
Danpanichkul P, Ng C, Muthiah M, Suparan K, Tan D, Duangsonk K, et al.
Am J Gastroenterol
. 2023 Dec;
119(5):893-909.
PMID: 38147513
Introduction: The burden of alcohol-related complications is considerable, particularly alcohol-associated liver disease and alcohol use disorder (AUD). However, there are deficiencies in comprehensive epidemiological research focusing on these issues, especially...
23.
Lee S, Tan D, Lim W, Ng C, Muthiah M, Huang D
Hepatobiliary Surg Nutr
. 2023 Dec;
12(6):916-918.
PMID: 38115945
No abstract available.
24.
Siddiqui M, Muthiah M, Satapathy S, Patidar K, Bhat M, Brandman D, et al.
Hepatology
. 2023 Dec;
PMID: 38088872
Occurrence of metabolic dysfunction-associated steatotic liver disease (MASLD) is common following liver transplantation (LT). MASLD can be classified as a recurrent disease when it occurs in patients receiving LT for...
25.
Koh J, Wang M, Suzuki H, Muthiah M, Ng C, Huang D
J Clin Exp Hepatol
. 2023 Dec;
14(1):101213.
PMID: 38076360
Non-alcoholic fatty liver disease (NAFLD) is rapidly emerging as a leading etiology of chronic liver disease (CLD) in Asia. The increasing incidence of NAFLD is projected to drive a surge...
26.
Tan D, Ng C, Muthiah M, Yong J, Chee D, Teng M, et al.
Metabolism
. 2023 Nov;
152:155744.
PMID: 38029839
Background: High body mass index (BMI) is a major risk factor for cancer development, but its impact on the global burden of cancer remains unclear. Methods: We estimated global and...
27.
Dalakoti M, Leow M, Khoo C, Yang H, Ling L, Muthiah M, et al.
Sci Rep
. 2023 Nov;
13(1):20521.
PMID: 37993612
Through extensive multisystem phenotyping, the central aim of Project PICMAN is to correlate metabolic flexibility to measures of cardiometabolic health, including myocardial diastolic dysfunction, coronary and cerebral atherosclerosis, body fat...
28.
Wong Z, Koh J, Muthiah M, Koh B, Ong E, Ong C, et al.
Dig Dis Sci
. 2023 Nov;
69(1):289-297.
PMID: 37968557
Background/aims: Proton pump inhibitors (PPIs) are frequently prescribed to cirrhotic patients, but there is limited longitudinal evidence regarding their effects. This study aimed to assess the impact of PPIs on...
29.
Tang A, Tan C, Lim W, Ng C, Tan D, Zeng R, et al.
Transplantation
. 2023 Oct;
108(5):1157-1165.
PMID: 37899382
Background: Preliver transplant diabetes mellitus (pre-LT DM) is a common comorbidity in LT recipients associated with poorer post-transplant survival. However, its relationship with other important outcomes, including cardiovascular and renal...
30.
Chan K, Ong E, Chung C, Ong C, Koh B, Tan D, et al.
Clin Gastroenterol Hepatol
. 2023 Sep;
22(3):488-498.e14.
PMID: 37775028
Background & Aims: The progression of metabolic dysfunction-associated steatotic liver disease (MASLD) has been found to manifest in a series of hepatic and extrahepatic complications. A comprehensive meta-analysis of the...